UK researchers find metastasis switch in b...Constitutive activation of the mechano-sensor and transcription factor Yes-associated protein (YAP) is key to metastasis and epithelial-mesenchymal transition of triple-negative breast cancer, researchers … more ➔
NeRRe Therapeutics pushes leads by €26m...Neuronal hypersensitivity specialist NeRRe Therapeutics has closed an oversubscribed Series B financing round led by Fountain Healthcare Partners. more ➔
Bayer antibiotics spin-out Aicuris bags IM...The Innovative Medicines Initiative is pushing clinical development of a novel compound against Gram-negative bugs that cause urinary tract and intra-abdominal infections. Backed by IMI, Aicuris is launching … more ➔
Tiziana joins rheumatoid arthritis raceThe London-based immunotherapy specialist Tiziana Life Sciences bagged the license for the human anti-interleukin 6 receptor antagonist NI-1201 from Swiss Novimmune. more ➔
Sanofi and Boehringer Ingelheim close ?bus...French Sanofi is set to become a global market leader in the non-prescription market by acquiring Boehringer Ingelheim’s consumer healthcare (CHC) business in exchange for Sanofi’s animal health … more ➔
Best of 2016: Our most wanted newsWhich European Biotechnology news stories topped the charts this year? The European Biotechnology team delved into archives and analysed the click statistics. And here they are: the most wanted news … more ➔
Blood test on the scent of prionsContaminated blood can transmit prion disease even if the donor does not yet show any symptoms. A new blood test could make the blood supply safer. Two reports show it can correctly diagnose Variant … more ➔
IMI launches €348m callElectronic submission systems of the Innovative Medicines Initiative (IMI) will open for biotech companies and research groups on 4 January 2017 to apply for collaborative projects with pharma partners … more ➔
Belgian spin-off Indigo challenges diabete... Indigo Diabetes NV has been spun-off from University of Ghent and international research institute imec with a series A financing of €7m. The company’s needle-free glucose sensor addresses … more ➔
EMA recommends market approval of four bio... The Europan Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended four biologics, among them three biosimilars, one monoclonal antibody as well as two targeted … more ➔
